Literature DB >> 32898832

Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China.

Guanmei Cao1, Yunyun Duan1, Ningnannan Zhang2, Jie Sun2, Haiqing Li3, Yuxin Li3, Yongmei Li4, Chun Zeng4, Xuemei Han5, Fuqing Zhou6, Muhua Huang6, Zhizheng Zhuo1, Sven Haller7, Yaou Liu8.   

Abstract

PURPOSE: To investigate the brain MRI features in neuromyelitis optica spectrum disorders (NMOSD) and its clinical relevance in a large multi-center cohort in China.
METHODS: 270 NMOSD patients were recruited from seven centers. The brain MRI were classified as normal, NMOSD-specific lesions, multiple sclerosis-like, nonspecific white matter changes. Brain volumes including whole brain, white, gray matter, cortex and subcortex gray matter volume were measured. The relationship between MRI measures, clinical disability and cognitive impairment were investigated.
RESULTS: 98 patients (36.3%) had normal brain MRI; 48 patients (17.7%) had NMOSD-specific lesions located in dorsal brainstem, corticospinal tract corpus, callosum and periependymal lesions surrounding the ventricular system; 16 patients (6%) had multiple sclerosis-like lesions; and 108 patients (40%) had nonspecific white matter changes. NMOSD patients with brain lesions had a trend of lower subcortex gray matter volume compared to patients without lesions. 52.5% patients with normal brain MRI and 50.8% patients with abnormal brain MRI showed cognitive impairment. No significant differences were identified in brain volume between cognitive impairment and cognitive preserved groups.
CONCLUSION: In this large multicenter NMOSD cohort, nonspecific white matter changes were the most common findings (40%). NMOSD patients with brain lesions demonstrated a trend of having lower brain volume than patients without lesions. Approximately 50% NMOSD patients presented cognitive impairment independent of brain lesions.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain abnormality; Brain volume; Cognitive impairment; MRI; Neuromyelitis optica spectrum disorders

Mesh:

Year:  2020        PMID: 32898832     DOI: 10.1016/j.msard.2020.102475

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  3 in total

1.  Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.

Authors:  Omri Zveik; Ariel Rechtman; Nitzan Haham; Irit Adini; Tamar Canello; Iris Lavon; Livnat Brill; Adi Vaknin-Dembinsky
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 2.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

Review 3.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.